A majority of Covid-19 patients that were admitted to U.S. hospitals during the first few months of the pandemic were prescribed antibiotics even before a bacterial infection had been confirmed, a study showed on March 10.
Allecra Therapeutics indicated the company’s Exblifep (cefepime-enmetazobactam) hit pre-specified primary endpoints in the Phase III ALLIUM clinical trial in complicated urinary tract infections, including acute pyelonephritis.
GlaxoSmithKline Plc started a late-stage study testing the company’s experimental antibiotic gepotidacin in patients with urinary tract infections and gonorrhoea.
